Latest AVI Biopharma Inc. Stories

2008-06-16 09:01:18

AVI BioPharma, Inc. (NASDAQ: AVII) today announced that its partner in its cardiovascular program, Global Therapeutics, the cardiology unit of Cook Medical, has received CE Mark approval for a new cobalt chromium bare metal stent. The device, the Global Therapeutics GTX Coronary Stent System, is also the platform for a breakthrough drug-eluting stent (DES) technology which utilizes AVI-5126, developed by AVI. The drug candidate is an improved version of antisense gene therapy to inhibit the...

2006-01-20 10:17:22

BOSTON (Reuters) - AVI BioPharma Inc. on Friday said a drug it is developing for certain strains of flu, including avian flu, looks promising in laboratory experiments. The drug, Neugene, is at such an early stage of development that it has yet to be tested in humans. Even so, the company's shares leaped as much as 37 percent to their highest level since April 2002. AVI said it planned to apply to the U.S. Food and Drug Administration for permission to conduct further tests against...

Word of the Day
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.